Wellcome Trust Centre for Mitochondrial Research, Institute for Ageing and Health, Medical School, Newcastle University, Newcastle upon Tyne, UK.
J Med Genet. 2012 Sep;49(9):569-77. doi: 10.1136/jmedgenet-2012-101146.
Isolated complex II deficiency is a rare form of mitochondrial disease, accounting for approximately 2% of all respiratory chain deficiency diagnoses. The succinate dehydrogenase (SDH) genes (SDHA, SDHB, SDHC and SDHD) are autosomally-encoded and transcribe the conjugated heterotetramers of complex II via the action of two known assembly factors (SDHAF1 and SDHAF2). Only a handful of reports describe inherited SDH gene defects as a cause of paediatric mitochondrial disease, involving either SDHA (Leigh syndrome, cardiomyopathy) or SDHAF1 (infantile leukoencephalopathy). However, all four SDH genes, together with SDHAF2, have known tumour suppressor functions, with numerous germline and somatic mutations reported in association with hereditary cancer syndromes, including paraganglioma and pheochromocytoma.
Here, we report the clinical and molecular investigations of two patients with histochemical and biochemical evidence of a severe, isolated complex II deficiency due to novel SDH gene mutations; the first patient presented with cardiomyopathy and leukodystrophy due to compound heterozygous p.Thr508Ile and p.Ser509Leu SDHA mutations, while the second patient presented with hypotonia and leukodystrophy with elevated brain succinate demonstrated by MR spectroscopy due to a novel, homozygous p.Asp48Val SDHB mutation. Western blotting and BN-PAGE studies confirmed decreased steady-state levels of the relevant SDH subunits and impairment of complex II assembly. Evidence from yeast complementation studies provided additional support for pathogenicity of the SDHB mutation.
Our report represents the first example of SDHB mutation as a cause of inherited mitochondrial respiratory chain disease and extends the SDHA mutation spectrum in patients with isolated complex II deficiency.
孤立的复合物 II 缺陷是一种罕见的线粒体疾病形式,约占所有呼吸链缺陷诊断的 2%。琥珀酸脱氢酶(SDH)基因(SDHA、SDHB、SDHC 和 SDHD)是常染色体编码的,并通过两个已知的组装因子(SDHAF1 和 SDHAF2)转录复合物 II 的共轭异四聚体。只有少数报道描述了遗传性 SDH 基因突变是小儿线粒体疾病的原因,涉及 SDHA( Leigh 综合征、心肌病)或 SDHAF1(婴儿脑白质病)。然而,所有四个 SDH 基因,连同 SDHAF2,都具有已知的肿瘤抑制功能,与遗传性癌症综合征相关的种系和体细胞突变报告众多,包括副神经节瘤和嗜铬细胞瘤。
在这里,我们报告了两名患者的临床和分子研究,这些患者具有组织化学和生化证据表明存在严重的孤立复合物 II 缺陷,这是由于新的 SDH 基因突变所致;第一个患者表现为心肌病和脑白质病,是由于复合杂合 p.Thr508Ile 和 p.Ser509Leu SDHA 突变所致,而第二个患者表现为肌张力减退和脑白质病,磁共振波谱显示脑内琥珀酸升高,这是由于一种新的纯合 p.Asp48Val SDHB 突变所致。Western 印迹和 BN-PAGE 研究证实相关 SDH 亚基的稳定状态水平降低,并且复合物 II 的组装受损。来自酵母互补研究的证据为 SDHB 突变的致病性提供了额外的支持。
我们的报告代表了 SDHB 突变作为遗传性线粒体呼吸链疾病的第一个例子,并扩展了孤立的复合物 II 缺陷患者中 SDHA 突变谱。